Table 3.
Mean values ± standard deviation (median values) recorded after the race.
| CT (sec) | CFT (sec) | MCF (mm) | α (°) | Vmax (mm/min) | AUC (mm2) | ||
|---|---|---|---|---|---|---|---|
| EXT | NC | 58.4 ± 10.4 | 150.4 ± 29.6 | 51.4 ± 5.4 | 63.8 ± 6.1 | 11.0 ± 2.3 | 5126.6 ± 511.0 |
| (57.0) | (148.0)* | (53.0)* | (66.0)* | (11.0) | (5252.0)* | ||
| E | 51.3 ± 7.9 | 137.8 ± 28.5 | 56.8 ± 5.4 | 66.8 ± 6.5 | 11.3 ± 2.1 | 5324.1 ± 367.5 | |
| (51.7) | (136.1)* | (56.1) | (67.2) | (11.9) | (5343.0)* | ||
| INT | NC | 257.±45.66 | 131.0 ± 28.3 | 45.0 ± 5.1 | 66.2 ± 4.0 | 11.0 ± 2.2 | 4527.8 ± 501.3 |
| (234.0) | (135.0) | (43.0) | (66.0) | (10.0) | (4318.0) | ||
| E | 262.6 ± 42.1 | 101.9 ± 15.4 | 49.8 ± 5.4 | 72.0 ± 3.5 | 14.0 ± 2.1 | 5002.2 ± 415.0 | |
| (247.9) | (100.6)* | (49.9)* | (71.0) | (14.1) | (4951.2)* | ||
| FIB† | NC | 52.0 ± 6.2 | Nd | 14.0 ± 3.6 | 68.0 ± 4.2 | 11.4 ± 2.9 | 1341.3 ± 348.2 |
| (54.0) | (14.0)* | (68.0) | (12.0)* | (1328.0)* | |||
| E | 48.2 ± 6.2 | Nd | 14.1 ± 3.9 | 70.9 ± 8.8 | 13.9 ± 5.1 | 1376.0 ± 414.7 | |
| (48.0) | (15.0)* | (75.0) | (14.0)* | (1398.0)* | |||
| LYS† | NC | 53.5 ± 5.9 | 180.5 ± 23.7 | 46.0 ± 3.0 | 61.0 ± 7.1 | 10.0 ± 2.4 | 4575.2 ± 269.7 |
| (53.5) | (183.0) | (45.0) | (60.5) | (10.5) | (4511.5) | ||
| E | 47.3 ± 5.3 | 144.7 ± 31.3 | 52.2 ± 4.8 | 66.5 ± 6.3 | 12.2 ± 2.5 | 5278.5 ± 475.5 | |
| (47.5) | (144.0) | (52.0)* | (67.0) | (12.0)* | (5186.5) |
NC: negative controls; E: EIPH; EXT: extrinsic pathway; INT: intrinsic pathway; FIB: fibrinogen activity; LYS: fibrinolysis; nd: not determinable; in bold: P < .05 versus the post-race NC value; *P < .05 versus the corresponding pre-race value of the same group; †Fibrinogen and fibrinolytic activities were determined in only 11 samples.